1. Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically Ill COVID-19 patients: The case for compassionate use;Atluri;Pain Physician,2020
2. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan;Chan;Emerging Microb. Infect.,2020
3. ClinicalTrials.gov, Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19. ClinicalTrials.gov, 20Identifier: NCT04252118. Accessed date 3/15/2020.
4. ClinicalTrials.gov, Umbilical Cord (UC)-Derived Mesenchymal Stem Cells (MSCs) Treatment for the 2019-novel Coronavirus (nCOV) Pneumonia. ClinicalTrials.gov, 2020. Identifier: NCT04269525. Accessed date 3/15/2020.
5. ClinicalTrials.gov, Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19. ClinicalTrials.gov, 2020. Identifier: NCT04273646. Accessed date 3/15/2020.